MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-25-2026
TELA Bio Market Cap 2011-2026 | TELA
As of April 07, 2026 TELA Bio has a market cap of $ 31.9 M
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap TELA Bio
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 32.4 M | 19.7 M | 131 M | 164 M | 177 M | 185 M | 26.1 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 185 M | 19.7 M | 105 M |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
EDAP TMS S.A.
EDAP
|
139 M | $ 3.42 | -2.43 % | $ 128 M |  France |
 |
GenMark Diagnostics, Inc.
GNMK
|
933 M | - | - | $ 1.77 B |  USA |
 |
Acutus Medical
AFIB
|
5.24 M | - | -26.83 % | $ 2.62 M | USA |
 |
AdaptHealth Corp.
AHCO
|
1.2 B | $ 11.96 | -0.95 % | $ 1.62 B | USA |
 |
FONAR Corporation
FONR
|
85.2 M | $ 18.59 | -0.08 % | $ 122 M | USA |
 |
Allied Healthcare Products
AHPI
|
4.01 M | - | 3.58 % | $ 2.21 M | USA |
 |
Lianluo Smart Limited
LLIT
|
147 M | - | 24.59 % | $ 44.8 M |  China |
 |
ClearPoint Neuro
CLPT
|
316 M | $ 9.14 | -2.56 % | $ 259 M | USA |
 |
Globus Medical
GMED
|
12.5 B | $ 90.44 | 2.08 % | $ 12.2 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
35 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bruker Corporation
BRKR
|
6.9 K | $ 36.34 | -1.09 % | $ 5.42 K | USA |
 |
Helius Medical Technologies
HSDT
|
3.54 M | $ 1.79 | -5.79 % | $ 1.09 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
1.88 B | $ 9.29 | -0.21 % | $ 715 M | USA |
 |
Inspire Medical Systems
INSP
|
1.76 B | $ 54.5 | 0.66 % | $ 1.6 B | USA |
 |
IRIDEX Corporation
IRIX
|
16.6 M | $ 1.0 | 0.34 % | $ 16.9 M | USA |
 |
Integer Holdings Corporation
ITGR
|
2.98 B | $ 85.22 | -0.48 % | $ 2.96 B | USA |
 |
Apollo Endosurgery
APEN
|
403 M | - | - | $ 475 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
437 M | $ 15.7 | -1.54 % | $ 368 M | USA |
 |
LENSAR
LNSR
|
71.3 M | $ 5.83 | -1.1 % | $ 69.7 M | USA |
 |
Medtronic PLC
MDT
|
111 B | $ 86.5 | 0.25 % | $ 111 B | USA |
 |
CryoLife, Inc.
CRY
|
906 M | - | -4.14 % | $ 702 M | USA |
 |
Myomo
MYO
|
33.9 M | $ 0.67 | -5.3 % | $ 28 M | USA |
 |
Avinger
AVGR
|
2.59 M | - | -20.74 % | $ 369 K | USA |
 |
Align Technology
ALGN
|
13.9 B | $ 167.2 | -2.72 % | $ 12.5 B | USA |
 |
CHF Solutions, Inc.
CHFS
|
1.05 M | - | 1.15 % | $ 34.5 M | USA |
 |
Orthofix Medical
OFIX
|
491 M | $ 11.72 | -0.4 % | $ 464 M |  Curacao |
 |
AxoGen
AXGN
|
1.5 B | $ 30.54 | -6.43 % | $ 1.41 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
2.82 B | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
Soliton, Inc.
SOLY
|
229 M | - | -1.42 % | $ 435 M | USA |
 |
Insulet Corporation
PODD
|
18.1 B | $ 204.83 | 0.65 % | $ 14.4 B | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.99 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
339 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
185 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
677 M | - | - | $ 111 M |  Canada |
 |
Sintx Technologies
SINT
|
6.91 M | $ 2.63 | 3.95 % | $ 7.29 M | USA |
 |
Butterfly Network
BFLY
|
766 M | $ 4.0 | -3.27 % | $ 847 M | USA |
 |
Smith & Nephew plc
SNN
|
29.7 B | $ 31.7 | -2.85 % | $ 23.8 B |  Britain |
 |
Intersect ENT, Inc.
XENT
|
735 M | - | - | $ 955 M | USA |
 |
Stryker Corporation
SYK
|
147 B | $ 331.21 | -0.33 % | $ 127 B | USA |
 |
Tactile Systems Technology
TCMD
|
640 M | $ 24.24 | -1.38 % | $ 554 M | USA |
 |
Cytosorbents Corporation
CTSO
|
34.8 M | $ 0.6 | 1.68 % | $ 37.3 M | USA |
 |
TransMedics Group
TMDX
|
4.69 B | $ 107.12 | 2.21 % | $ 3.64 B | USA |
 |
Tandem Diabetes Care
TNDM
|
1.26 B | $ 18.93 | -1.28 % | $ 1.29 B | USA |
 |
BIOLASE
BIOL
|
192 K | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
326 M | $ 9.66 | -0.41 % | $ 346 M | USA |
 |
BioSig Technologies
BSGM
|
7.3 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
113 B | $ 61.25 | -2.14 % | $ 90.7 B | USA |
 |
Alphatec Holdings
ATEC
|
2.07 B | $ 11.14 | 1.55 % | $ 1.67 B | USA |